How G protein-coupled receptor conformational dynamics control G protein coupling to trigger signaling is a key but still open question. We addressed this question with a model system composed of the purified ghrelin receptor assembled into lipid discs. Combining receptor labeling through genetic incorporation of unnatural amino acids, lanthanide resonance energy transfer, and normal mode analyses, we directly demonstrate the occurrence of two distinct receptor:Gq assemblies with different geometries whose relative populations parallel the activation state of the receptor. The first of these assemblies is a preassembled complex with the receptor in its basal conformation. This complex is specific of Gq and is not observed with Gi. The second one is an active assembly in which the receptor in its active conformation triggers G protein activation. The active complex is present even in the absence of agonist, in a direct relationship with the high constitutive activity of the ghrelin receptor. These data provide direct evidence of a mechanism for ghrelin receptor-mediated Gq signaling in which transition of the receptor from an inactive to an active conformation is accompanied by a rearrangement of a preassembled receptor:G protein complex, ultimately leading to G protein activation and signaling.
How G protein-coupled receptor conformational dynamics control G protein coupling to trigger signaling is a key but still open question. We addressed this question with a model system composed of the purified ghrelin receptor assembled into lipid discs. Combining receptor labeling through genetic incorporation of unnatural amino acids, lanthanide resonance energy transfer, and normal mode analyses, we directly demonstrate the occurrence of two distinct receptor:Gq assemblies with different geometries whose relative populations parallel the activation state of the receptor. The first of these assemblies is a preassembled complex with the receptor in its basal conformation. This complex is specific of Gq and is not observed with Gi. The second one is an active assembly in which the receptor in its active conformation triggers G protein activation. The active complex is present even in the absence of agonist, in a direct relationship with the high constitutive activity of the ghrelin receptor. These data provide direct evidence of a mechanism for ghrelin receptor-mediated Gq signaling in which transition of the receptor from an inactive to an active conformation is accompanied by a rearrangement of a preassembled receptor:G protein complex, ultimately leading to G protein activation and signaling.
GPCR | G protein | preassembly | conformation dynamics | signaling G protein-coupled receptors (GPCRs), one of the largest cell surface receptor families, are involved in many cellular signaling processes (1) . Based on this property, as well as their importance as drug targets, the molecular aspects of GPCR functioning have been extensively investigated. In particular, coupling to heterotrimeric G proteins has been the focus of numerous studies. Indeed, delineating the molecular mechanisms responsible for receptor:G protein interaction is absolutely required to better understand how signaling is controlled. Recent years have seen spectacular advances that have culminated in elucidation of the 3D structure of the β 2 -adrenergic receptor:Gs complex (2). Nevertheless, the need for further progress remains, in particular to fully understand the dynamics of this interaction. This is a crucial question, given that how the receptor interacts with its G protein partner governs signaling, and thus biological and pathophysiological responses.
To date, two different models for GPCR:G protein interaction have been proposed: collision coupling and preassembly. Originally, it was proposed that receptors and G proteins couple by collision (3, 4) . One of the main features of this model is that only activated receptors interact with G proteins. Since then, alternative models of signaling have been developed. One of these, the preassembly model, proposes that the receptor and the G protein make a complex even in the absence of agonist (5) (6) (7) (8) .
Discriminating between the two models is crucial. Indeed, signaling outputs, such as the kinetics of G protein activation, will be significantly different depending on whether the ligand-free receptor is always in complex with its G protein or must first be activated by the agonist to recruit the G protein and trigger signaling. Moreover, it has been shown that GPCR conformational dynamics (9) (10) (11) and signaling in the absence of ligand are key features of GPCR functioning (12) . How receptor constitutive activity and conformational dynamics relate to their coupling to the G protein remains an open question.
Here we used the purified ghrelin receptor GHS-R1a to analyze the way in which this GPCR interacts with its G protein partners. Ghrelin is a neuroendocrine peptide hormone that acts through its cognate GPCR to control important biological processes, such as growth hormone secretion, food intake, and reward-seeking behaviors (13) . Among the GPCRs, GHS-R1a has been shown to have one of the highest basal Gq activation levels both in vitro (10, 14) and in vivo (15, 16) . The physiological relevance of GHS-R1a basal activity is substantiated by the occurrence of a natural human mutation in the GHS-R1a gene (A 204 E substitution in the second extracellular loop of the receptor) Significance G protein-coupled receptors (GPCRs), one of the largest cell surface receptor families, transmit their signals through the coupling of intracellular partners, such as the G proteins. Knowing how this coupling occurs is essential, because it governs the entire signaling process. To address this open question, we used a purified GPCR as a model to which we applied various state-of-the-art biochemical and biophysical approaches. By doing so, we provide direct experimental evidence of a signaling mechanism in which receptor conformational changes are directly linked to a rearrangement of a preassembled complex between the receptor and its cognate Gq protein. This sheds light on the way in which a GPCR interacts with G proteins to trigger signaling.
that dramatically decreases constitutive activity and is associated with a short-stature phenotype (17) . Along with its importance in drug design, GHS-R1a is a prototype for peptide-activated class A GPCRs.
To delineate the way in which the ghrelin receptor interacts with G proteins, we used monomeric GHS-R1a reconstituted in a membrane-mimicking environment, lipid discs, and a combination of innovative biochemical [labeling with unnatural amino acid (UAA)] and biophysical [lanthanide resonance energy transfer (LRET) and normal mode (NM) analyses] approaches. By doing so, we provide the first direct evidence that ghrelin-mediated signaling involves a complex dialogue between the conformational dynamics of the receptor and its ability to interact with the different G protein subtypes to which it is coupled.
Results
Receptor and Gq Labeling for LRET Measurements. Site-specific labeling of the ghrelin receptor and its cognate Gq protein was first required to monitor their interaction with LRET. The G protein was labeled on the free amino terminus of its α q subunit with the donor fluorophore (Lumi4-Tb) through a classical reaction with its N-hydroxysuccinimide (NHS) derivative at neutral pH (18) . This allowed specific labeling at the Gα q N terminus with ∼60% efficacy. Incomplete labeling does not affect LRET measurements, because only the emission of the acceptor originating from energy transfer exclusively (sensitized emission) is measured (19) . Modification of the α q subunit did not affect the ability of the G protein trimer to become activated (SI Appendix, Fig. S1A ).
The purified GHS-R1a was labeled through UAA technology. To this end, the pEVOL vector (20) was used to encode p-azido-L-phenylalanine (azidoF) into the ghrelin receptor sequence in response to a unique amber stop codon. AzidoF was inserted in the cytoplasmic face of GHS-R1a, where it replaced F 71 at the cytoplasmic tip of TM1 (SI Appendix, Fig. S2 ). This modification did not affect either ligand binding or G protein activation (SI Appendix, Fig. S3 ). The azidoF-containing receptor was assembled as a monomer into lipid discs (10) and then labeled with the fluorescence acceptor (Alexa Fluor 488) using the strain-promoted alkyne-azide cycloaddition reaction (21, 22) . Approximately 90% of labeling was achieved under these conditions, whereas no labeling was observed with the unmodified receptor (SI Appendix, Fig. S4 ).
LRET-Monitored GHS-R1a:Gq Interaction. LRET measurements were first carried out between the Gα q β 1 γ 2 trimer in which the α subunit was labeled at its N terminus with the donor fluorophore and the purified ghrelin receptor labeled with the green acceptor at the intracellular end of TM1. Measurements were done by monitoring the decay in the acceptor-sensitized emission, so that only the donor and acceptor engaged in LRET were detected. This compensates for partial labeling of the G protein. In all of the experiments, we systematically used the monomeric receptor assembled into lipid discs, because this monomer is fully functional with regard to G protein activation (10) .
In the absence of ligand, the fluorescence decay was best fitted by a double exponential function (Fig. 1A) , with the occurrence of two different lifetimes, τ ad 1 and τ ad 2 ( Fig. 1B and Table 1 ). Because distinct emission decay lifetimes are related to distinct transfer efficiencies, and thus to distinct donor-to-acceptor distances, these data indicate the occurrence of two equally populated receptor:G protein assemblies with different geometries (Fig. 1C) . The distance between the donor and the acceptor in each of these assemblies was estimated using the time constants of the acceptor-sensitized emission and the donor-only emission (Table 1) . Importantly, the population associated with τ ad 2 was abolished in the presence of GTPγS, whereas that associated with τ ad 1 was essentially unaffected (SI Appendix, Fig. S5 ), suggesting that the former is active with regard to Gq activation, but the latter is not.
We next investigated the effects of the binding of different ligands-the neutral antagonist JMV3011 (23), the full agonist MK0677 (24) , and the inverse agonist SPA (14)-on the acceptorsensitized emission profiles. No difference between the ligandfree and antagonist-loaded receptor was observed (SI Appendix, Fig. S6A ). In the presence of MK0677, the fluorescence decay was still best fitted by a double exponential function (Fig. 1A) , with lifetime values in the same range as those measured in the absence of ligand (Table 1) . A similar profile was obtained with the natural agonist ghrelin (SI Appendix, Fig. S7 ), indicating that the two trigger similar effects. A comparison of the apoand MK0677-loaded states showed that the distribution of τ ad 1 and τ ad 2 changed in favor of τ ad 2 in the presence of MK0677 (Fig. 1B) . This finding suggests that activation of the ghrelin receptor by its agonist populates the receptor:G protein complex associated with τ ad 2 ( Fig. 1C ). This complex certainly corresponds to an active one, given that MK0677 binding is accompanied by increased receptor-catalyzed G protein activation (SI Appendix, Fig. S3B ). In contrast, no significant acceptorsensitized emission signal could be measured in the presence of SPA (Fig. 1A) , suggesting that SPA dissociates the receptor:G protein complex (Fig. 1C) . Consistent with this conclusion, the fluorescence decay of the donor obtained under these conditions was similar to that measured in the presence of unlabeled receptor (SI Appendix, Fig. S8 ).
Effects of GHS-R1a Constitutive Activity on Its Interaction with Gq. To assess whether the occurrence of the active complex in the absence of ligand is related to the high constitutive activity of the ghrelin receptor, we investigated the interaction between Gq and the A 204 E mutant of GHS-R1a. As is the case in cellular systems (17, 25) , the purified A 204 E mutant exhibits significantly decreased constitutive activity while it can be fully activated with MK0677 (SI Appendix, Fig. S9 ).
The mutant was labeled as described above for the WT receptor, and its interaction with the labeled α subunit in Gα q β 1 γ 2 was monitored using LRET. In this case, the acceptor-sensitized emission decay was still best fitted by a double exponential function, but with a very major population with a lifetime decay closely related to τ ad 1 ( Fig. 1 D and E and Table 1 ). Combined with the near absence of receptor-catalyzed GDP/GTP exchange under such conditions (SI Appendix, Fig. S9 ), this finding indicates that (i) τ ad 1 is associated with an inactive complex, and (ii) the significant fraction of active GHS-R1a:Gq complex seen in the WT receptor is likely related to its high constitutive activity.
The lifetime distribution profiles in the presence and absence of the neutral antagonist were similar for the A 204 E mutant (SI Appendix, Fig. S6B ). In the presence of the full agonist MK0677, the lifetime distribution was closely related to that observed with the WT receptor, with the occurrence of two populations, a minor one (τ ad 1) and a major one (τ ad 2) (Fig. 1E and Table 1 ). This finding is in agreement with the fact that the WT receptor and the mutant can be equally activated by MK0677 (SI Appendix, Fig.   S9 ). Finally, no LRET signal could be measured in the presence of SPA (Fig. 1 D and F) . The differences in the coupling of the WT receptor and its A 204 E mutant to Gq are indicative of differences in the conformational features of these two proteins in their ligand-free state. We assessed these differences on an experimental basis using intramolecular LRET. In this case, the fluorescence acceptor was still introduced at the cytoplasmic end of TM1 as described above, whereas the donor was attached to the receptor through a unique reactive cysteine in the intracellular tip of TM6 (SI Appendix, Fig. S2 ). Both the WT and A 204 E mutant double-labeled proteins maintained their ability to bind ligands and activate G proteins (SI Appendix, Fig. S3 ). All of the foregoing experiments were carried out in the presence of the Gα q β 1 γ 2 trimer, because this affects the receptor conformational transitions (10, 26) , and thus its influence should be taken into account.
In the absence of ligand, the acceptor-sensitized emission decay of the WT receptor was best described by a double exponential function ( Fig. 2A and Table 2 ). This indicates that the ligand-free WT GHS-R1a is characterized by the occurrence of at least two different conformational states in essentially equal amounts, designated herein as basal and active conformations for Gq. The distances between fluorescent probes in these two conformations are in the 30-Å (basal) and 40-Å (active) ranges (Table 2) . Importantly, these two conformationally distinct receptor populations likely are related to the two populations of receptor:G protein complexes; indeed, they are equally populated (SI Appendix, Fig. S10 ). The acceptor-sensitized emission decay of the ligand-free A 204 E mutant also was best fitted by a double exponential function (Fig. 2B ), but with a very major population with a lifetime value closely related to that of the basal state for Gq (Table 2) .
We next assessed the effects of ligands on the distribution of GHS-R1a conformations. As shown in Fig. 2 , the intramolecular fluorescence decay profiles obtained for the WT and mutant receptors in the presence of MK0677 were essentially undistinguishable, with the occurrence of a major population with a lifetime value closely related to that of the active state for Gq (Table 2) . Again, the occurrence of a major conformational state closely parallels the occurrence of a major receptor:G protein population in the intermolecular LRET measurements (SI Appendix, Fig. S10 ). In the presence of the inverse agonist, the LRET profiles were best fitted with a single exponential function with a lifetime different from that of either the basal or the active conformation (Table 2) , suggesting the occurrence of a different conformational state (designated ground conformation for Gq). Finally, in the presence of JMV3011, no significant change was observed in the acceptor-sensitized emission profiles of both the WT receptor and the A 204 E mutant, indicating that this antagonist does not affect the conformational landscape of the receptor (SI Appendix, Fig. S11 ).
A Structural Basis for the Changes in LRET. We performed NM analysis to assess whether the distances inferred from our experimental LRET measurements are consistent with the structural arrangement of a GPCR in complex with a G protein. NM analysis is considered one of the best techniques for providing key information on the functional, collective motions of proteins (27) . Because the β 2 -adrenergic (β 2 AR):Gs complex is the only one for which an X-ray structure is available, we used it as a model (2) . It can be reasonably assumed that the general organization of both class A receptors, GHS-R1a and β 2 AR, should not be strikingly different, as was subsequently confirmed by the similarity between the distances measured experimentally with GHS-R1a and those inferred from the β 2 AR structures (see below).
The two residues in β 2 AR that correspond to the labeled positions in GHS-R1a, F 61 (TM1) and C 251 (TM6), were identified based on a multiple sequence alignment grouping of 200 human GPCR sequences from the Swissprot database and 20 different receptor structures from the Protein Data Bank. The mean distance measured between C 251 (Cβ atom) and F 61 (Cζ atom) through the 20-ns molecular dynamics trajectory was in the 39 Å range, in perfect agreement with the value of 39.9 Å measured for the active conformation of GHS-R1a.
The distance between the receptor and the G protein inferred from LRET was more difficult to confirm because of the lack of residues 1-8 at the N terminus of the Gα s structure. Nevertheless, the mean distance of ∼43 Å between T 9 (Gα s ; Cβ atom) and F 61 (TM1; Cζ atom) all along the molecular dynamics trajectory was again in good agreement with the ∼45 Å measured experimentally. Finally, an extrapolation of lacking residues at the C terminus of TM6 in the inactive β 2 AR structure (28) suggested that the F 61 :C 251 distance in this structure could be ∼25 Å, a value again in agreement with the 25.7 Å measured experimentally for the SPA-loaded GHS-R1a.
To assess whether the changes in distance inferred from LRET are compatible with possible motions in a GPCR:G protein complex, we analyzed the changes in the TM1:TM6 and TM1: GαN-TER distances along the 10 lowest-frequency NMs computed for the β 2 AR:Gs complex. As shown in Fig. 3A , the plot thus obtained shows that these two distances can vary between 39 Å and 30 Å for the TM1:TM6 distance and between 45 Å and 30 Å for the TM1:GαN-TER distance, in full agreement with our LRET data. Importantly, the TM1:TM6 and TM1:GαN-TER distances were usually seen to increase or decrease simultaneously, as was the case experimentally.
To exclude the possibility that the distance changes in the NM analyses were biased by the fact that NM techniques are performed in vacuo, we used a new, original approach, termed molecular dynamics with excited normal modes (MDeNM), to explore the conformational space along a given normal mode direction when including the membrane and water (Fig. 3B and SI Appendix). These calculations confirmed that the large, collective motion of the receptor observed in vacuo was still possible in the presence of the membrane and surrounding water molecules. Importantly, although the amplitudes of most of the modes were reduced after reintroduction of the membrane, mode 16 was unaffected (Fig. 3C) ; thus, the motion of the receptor along this mode (SI Appendix, Fig. S12 and Movie S1) could represent that observed experimentally.
GHS-R1a:G Protein Preassembly Depends on the G Protein Subtype.
Because GHS-R1a can trigger activation of Gi as well as Gq (29), the foregoing data raise the question of whether preassembly is common to all G protein subtypes. To assess this point on an experimental basis, we labeled Gα i2 with Lumi4-Tb under conditions similar to those used with Gα q , also with an efficacy in the 50-60% range. This modification did not affect the activity of the purified Gi protein (SI Appendix, Fig. S1B) .
In contrast to what was observed with Gq, no significant acceptor-sensitized emission signal could be measured in the absence of ligand for either the WT receptor or its A 204 E mutant (Fig. 4 A and B) , indicating that that there is no preassembly between the ligand-free receptor and Gα i2 β 1 γ 2 . This finding is consistent with our previous study in which, in contrast to Gq, Gi did not affect the conformation of the monomeric ghrelin receptor in the absence of ligand (10) . In the presence of the full agonist MK0677, however, a significant acceptor-sensitized emission signal was measured (Fig. 4 A and B) , indicating Gi recruitment on receptor activation.
A possible explanation for the foregoing finding is that the differences in the interaction mode of the ghrelin receptor with Gi and Gq result in differences in the kinetics of GHS-R1a-catalyzed G protein activation. To assess this point on an experimental basis, we monitored the kinetics of G protein activation in HEK293T cells using BRET-based Gq and Gi protein activation sensors (30) . As shown in Fig. 4 C and D, significant differences in the activation kinetics of both G proteins subtypes Table 2 . Sensitized emission lifetimes measured from the ghrelin receptor tagged with the donor and acceptor fluorophore, and corresponding distances between the cytoplasmic ends of TM1 and TM6 were observed with GHS-R1a in the presence of MK0677; that is, activation of Gq occurred significantly faster than activation of Gi. In the case of GHS-R1a, the kinetics of Gi activation also was significantly slower than that measured for the Gi-coupled α 2C AR (Fig. 4E ).
Discussion
Our LRET data directly demonstrate that in the absence of ligand and the presence of Gq, the ghrelin receptor is a dynamic protein that displays at least two different conformations for Gq, a basal one and an active one. The agonist further stabilizes the active conformation, whereas an inverse agonist stabilizes an additional inactive conformational state (ground state for Gq). Associated with the basal and active receptor conformations are two different receptor:Gq complexes (see the model in SI Appendix, Fig. S13 ). The first complex, associated with the active state of GHS-R1a, is an active assembly responsible for receptorcatalyzed GDP-to-GTP exchange. The second GHS-R1a:Gq complex is associated with the basal receptor conformation of the ghrelin receptor and is characterized by a different structural arrangement than that of the active complex. The fact that this second type of complex is the major one under conditions in which no G protein activation is observed (e.g., for the A 204 E mutant in the absence of agonist) and is not affected by GTPγS suggests that it is inactive with regard to receptor-catalyzed GDP/ GTP exchange. Thus, it is mechanistically distinct from the active assembly and likely corresponds to a preassembled GHS-R1a:Gq inactive complex.
Because LRET reports for proximity but not necessarily for a direct interaction, we cannot totally exclude the possibility that preassembly results from an interaction of the G protein with the lipid bilayer of the nanodisc rather than with the receptor. The preassembled complex is readily dissociated on binding of the inverse agonist, however. Moreover, no LRET signal was observed with lumi4-Tb-labeled Gq or Gi and empty discs containing fluorescein-labeled lipids (SI Appendix, Fig. S14 ). This strongly indicates that the preassembled GHS-R1a:Gq complex results, at least to some extent, from a direct interaction of Gq with the ghrelin receptor.
Importantly, GHS-R1a:G protein preassembly was observed with Gq but not with Gi. This finding is reminiscent of what has been proposed for PAR1 that is preassembled to Gi but not to G12 (31) . This means that the basal conformation of the ghrelin receptor that is competent for interaction with Gq, although in a nonproductive way, is not competent for interaction with Gi, suggesting slight but nevertheless significantly different modes of interaction between the receptor and its different G protein subtype partners, as has been proposed for Gs and Gi (32) . A possible explanation for this may be that the affinity of the ghrelin receptor in its basal conformation is lower for Gi than for Gq. Regardless of the mechanistic details, this implies that GHSR1a signaling along its different G protein-dependent pathways involves an intricate dialogue between receptor conformational transitions and interaction with distinct G protein subtypes.
Our intramolecular LRET data demonstrate the occurrence of two different conformations of the ghrelin receptor that are inactive with regard to Gq activation. The first of these conformations is the basal state, which is observed for the WT receptor in the absence of ligand and is the major species for the constitutively inactive A 204 E mutant. The second is the ground conformation stabilized by the inverse agonist. This means that two distinct conformational states can give rise to a similar functional output (i.e., no Gq activation). Both states nevertheless differ in their ability to interact with the G protein. Whereas the basal conformation is responsible for the inactive preassembled complex with Gq, no receptor:G protein interaction was observed with the ground state stabilized by SPA. A possible explanation for this finding is that the GHS-R1a basal state represents some sort of a preactivated conformation able to make a stable complex with its G partner as a first step along the Gq signaling pathway.
Importantly, NM analyses using the β 2 AR:Gs complex as a model are fully consistent with our intramolecular and intermolecular LRET experiments. This strongly indicates that the distances and their changes that we measured experimentally are totally relevant on a structural basis. Adding consistency to our conclusions, our NM analyses revealed that the antisymmetric rotation of the receptor on activation also promoted a coupled motion of the G protein in which the Gα and Gβγ subunits deviate from each other (SI Appendix, Fig. S12 ), in agreement with previous FRET/BRET data (7) .
In contrast to the WT receptor, the constitutively inactive A 204 E mutant in its apo state displays a major conformation, the basal one. The observation that the inactive mutant is frozen in a basal inactive conformation, whereas the WT receptor oscillates between this same basal state and an active state, provides an additional piece of evidence for the model in which the absence of constitutive activity is associated with reduced conformational dynamics of GHS-R1a (25) . Restriction of the conformational flexibility of the A 204 E mutant could result from an additional structural constraint introduced at the level of the e2 loop on substitution of the A 204 residue (25) . Consistent with occurrence of the basal conformation as a major state, the inactive preassembled complex is the major species in the case of the ligandfree, constitutively inactive A 204 E mutant. It has been shown that the ghrelin receptor can function as a dimer (33) . Dimerization may add an additional level of complexity to the interaction of GHS-R1a with its cognate G proteins. For instance, we have shown that homodimers are asymmetric assemblies with one protomer in its active state and the other in the basal conformation for Gq (34) . If the behavior of GHS-R1a protomers with regard to interaction with G proteins is similar in the monomer and in the dimer, then each of the protomers within the asymmetric dimer should have a different mode of interaction with Gq. Thus, dimerization likely will impact the way in which GHS-R1a couples to Gq, but the extent to which it will affect preassembly remains to be delineated.
In closing, our data provide a direct experimental evidence for a specific receptor:Gq protein preassembly, as well as a plausible mechanism for the consequences of the receptor conformational transitions on the assembly with one of its main signaling partners, Gq. Ultimately, this sheds light on the relationships between the conformational dynamics of a GPCR and how it will interact with its cognate G protein partner to trigger signaling.
Materials and Methods
UAA Labeling. The TAG amber codon was introduced by site-directed mutagenesis into the pET21a-α5-GHS-R1a vector (10) at the position encoding F 71 of GHS-R1a. This mutation also was introduced in a cysteine-free mutant (10) with single reactive cysteine at position 255. The same modifications were introduced in the vector encoding the A 204 E mutant. Incorporation of the modified amino acid was then carried out as detailed in SI Appendix.
Protein Labeling. Labeling of Gα q and Gα i2 on their N termini with the Lumi4-terbium (Tb) cryptate (CisBio) was carried out using the NHS derivative of the fluorophore at neutral pH (18) (SI Appendix). For labeling GHS-R1a on Cys 255 , the purified receptor was incubated with the fluorescence donor overnight at 16°C in the presence of 100 μM tris(2-carboxyethyl)phosphine (SI Appendix). Coupling of Alexa Fluor 488 to azidoF 71 was performed by overnight incubation of the receptor with Click-IT Alexa Fluor 488 DIBO Alkyne (Life Technologies) (SI Appendix).
Spectroscopy. A cuvette-based fluorescence lifetime spectrometer with a highpowered pulsed Xe lamp as the excitation source was used for all fluorescence measurements (excitation 337 nm). Donor-only lifetimes were recorded using the labeled G protein and unlabeled receptor under the same conditions. The fluorescence decays at 515 nm were normalized to the maximum fluorescence and fitted to a sum of discrete exponential functions. The distances between the donor and acceptor fluorophores were calculated using the LRET lifetime (τ ad ) and donor-only lifetime (τ d ) using the Förster equation (35) (SI Appendix).
BRET 2 -Monitored G Protein Activation. Receptor and G protein sensor constructs (7, 30) were transiently cotransfected into HEK293T cells. For kinetics analyses, 5 μM deep blue C (Interchim) was added before injection of the ligand (1 μM). The net BRET signal was obtained by calculating the ratio of GFP10 emission (515 ± 10 nm) over Rluc8 light emission (400 ± 10 nm) (SI Appendix).
NM Analyses. The NM analyses are described in SI Appendix.
